Febuary
1, 2001
Progress on the fight
against diabetes.
For a number of years
scientists have been developing
"statin" a cholesterol-lowering drug to
help reduce the risk of another heart attack and
the need for artery opening procedures in people
with diabetes and hear disease. In December of
1998, Circulation, the Journal of the American
Heart Association, reported the findings of the
most recent study indicating that indeed people
with diabetes and heart disease who have average
blood levels of cholesterol would benefit from
statin drug therapy.
Dr. Frank M. Sacks co-author
of the report said that compared with diabetic
patients who received Pravastatin had a 25 per
cent reduction in relative risk of having another
heart attack. And, the relative risk of needing
coronary artery bypass or angioplasty to unblock
blood vessels was reduced by 32 per cent in the
statin-treated group of those tested.
Now, on January 23, 2001,
Circulation reported that the statin drug used
has shown it reduces the risk of Type 2 diabetes.
"This is significant
because it is the first time that treatment with
a statin has been shown to have an impact on the
development of diabetes," stated Dr. Allan
Gaw, the senior author of the January article.
Dr. Gaw's team made the
discovery by analyzing data from the West of
Scotland Coronary Prevention Study designed to
determine the effectiveness of Pravastatin in
preventing a first hear attack in people with
high cholesterol.
They found that those given
Pravastatin had a 30 per cent reduced risk of
developing diabetes.
He and his colleagues used
data from 5,974 men, ages 45 to 64, to examine
the effect of Pravastatin on the development of
diabetes. Among the men, 153, or 2.6 per cent,
developed the disease. The 30 per cent risk
reduction for diabetes that they found among
Pravastatin users was an attention getter.
However, Dr. Gaw cautioned that further
randomized studies are needed to confirm the
findings.
"Also, we need to do
some more basic science work to unravel the
precise mechanism for this interesting and
potentially very important finding," he
added.
[
|